Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 21, 2024 at 07:14 AM.
Here's what investors need to know about the announcement.
Earnings
Milestone Pharmaceuticals missed estimated earnings by -3.0%, reporting an EPS of $-0.32 versus an estimate of $-0.31.
Revenue was down $3.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 4.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.